Xylazine 10%

Xylazine is an α2-adrenergic agonist with analgesic, sedative, and muscle relaxant properties. Its sedative and analgesic activity is associated with central nervous system depression. The muscle relaxant effect is based on the inhibition of intraneural transmission of impulses in the central nervous system; the main effects develop within 10 to 15 minutes after IM injection and within 3 to 5 minutes after IV injection.

BENEFITS:

•High safety in use, both for the veterinarian and the animal.
•Sedation is more satisfactory if the animal is tranquilized before administering the anesthetic.
•It allows for the management of minor interventions and the use of general anesthesia for major interventions.
•Using 10% Cheminova Xylazine, there is a significant saving in anesthetic.

DOSE:

Depending on the type and degree of effect desired, the following are recommended:

the following doses:

Intravenous: 0.5 to 1.1 mg/kg of body weight

(equivalent to 0.25-0.55 mL/50 kg of body weight).

Intramuscular route: 1 to 2 mg/kg of body weight

(equivalent to 0.5-1 mL/50 kg of body weight).

The dose depends on the degree of sedation sought and the time

duration of effect.